Health News Releases

  • Today February 17
February 05, 2020 11:50
Takeda Demonstrates Business Momentum, Accelerated Integration Synergies, and Raises FY2019 Guidance Including Positive Reported Operating Profit
Takeda Pharmaceutical Company Limited (TOKYO:4502)(NYSE:TAK): This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200203005855/en/ Underl
February 05, 2020 09:07
Rebiotix, a Ferring Company, Completes Enrollment for First-Ever, Pivotal Phase 3 Clinical Trial of Microbiota-based RBX2660
Rebiotix, a Ferring company, announced today that it has completed enrollment of the pivotal Phase 3 clinical trial for RBX2660, an investigational therapy aimed at breaking the cycle of recurrent Clo
February 05, 2020 08:28
Boehringer Ingelheim receives approval for Aservo® EquiHaler®, industry first therapy for severe equine asthma
Horses with severe equine asthma struggle to breath, even at rest. Last week, the European Commission granted marketing authorization[1] to Boehringer Ingelheim for the new Aservo® EquiHaler® - and ho
February 04, 2020 13:22
Patient Safety Movement Foundation Urges Clinicians, Patient Advocates, Hospitals & Medical Technology Companies to Support Data Sharing as Part of the 2020 Federal Health IT Plan
Patient Safety Movement Foundation is urging clinicians, patient advocates, hospitals and medical technology companies to support Data Sharing as part of the 2020 Federal Health IT plan. “One of th
February 04, 2020 11:41
Teva Announces Positive Top-Line Results from AJOVY® (fremanezumab) Clinical Trials in Japan
Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) today announced positive results from two Phase 2/3 trials evaluating AJOVY® (fremanezumab) in patients in Japan. AJOVY is under development i
February 04, 2020 09:57
Jabil Launches Jabil Healthcare, the Largest Healthcare Manufacturing Solutions Provider
Jabil Inc. (NYSE: JBL) today announced the consolidation of its entire healthcare organization under Jabil Healthcare, led by Steve Borges, CEO and EVP. Jabil Healthcare combines, under a single umbre
February 03, 2020 10:23
Merz Aesthetics Presents Data at the IMCAS World Congress 2020
Merz, a global leader in medical aesthetics, announced today that data on the Merz Aesthetics product portfolio, including Belotero®, Cellfina® and Radiesse® will be featured in oral and poster presen
February 03, 2020 08:55
OncoSec Urges Shareholders to Focus on the Critical Benefits of CGP/Sirtex Transaction
OncoSec Medical Incorporated (NASDAQ:ONCS) (the “Company” or “OncoSec”), a company developing late-stage intratumoral cancer immunotherapies, today issued the following statement to its shareholders r
January 29, 2020 09:22
OncoSec Urges Shareholders Not to Fall for Alpha’s Disingenuous “Proposal” and Scheme to Prevent Fair Vote at Special Meeting
OncoSec Medical Incorporated (NASDAQ:ONCS) (the “Company” or “OncoSec”), a company developing late-stage intratumoral cancer immunotherapies, today issued the following statement to its shareholders r
January 28, 2020 13:25
Rare Disease CDKL5 Deficiency Disorder Granted WHO Disease Classification
The rare genetic disease CDKL5 Deficiency Disorder (CDD) has been designated with a new disease code in the International Classification of Diseases (ICD), the medical classification list from the Wor
January 27, 2020 11:40
Amazentis Announces the Launch of Timeline™ Cellular Nutrition at the World Economic Forum in Davos
Amazentis announces the debut of Timeline, a next generation nutrition product designed to promote healthy aging, as part of the Swiss Food & Nutrition Valley in the House of Switzerland at the World
January 27, 2020 11:33
President Bill Clinton to Keynote 2020 World Patient Safety, Science & Technology Summit
President Bill Clinton, the 42nd President of the United States, will be the closing keynote speaker at the Patient Safety Movement Foundation’s 2020 World Patient Safety, Science & Technology Summit.
January 22, 2020 16:00
PDC*line Pharma Raises €20 Million in Series B Financing Round
PDC*line Pharma, a clinical stage biotech company developing a new class of potent and scalable active immunotherapies for cancers, announces today the completion of its Series B round of financing. T
January 22, 2020 11:35
Takeda Named Global Top 100 Most Sustainable Corporation for Fifth Year Running
Takeda Pharmaceutical Company Limited (TOKYO:4502/NYSE:TAK) (“Takeda”) is proud to be named in the Corporate Knights Global 100 Most Sustainable Corporations in the World (Global 100) for the fifth co
January 22, 2020 09:42
OncoSec Sends Letter Urging Shareholders Not to Be Distracted by Alpha’s Last-Ditch Efforts to Derail CGP/Sirtex Transaction
Daniel O’Connor, President, Director & CEO of OncoSec Medical Incorporated (NASDAQ:ONCS), a company developing late-stage intratumoral cancer immunotherapies, today sent the following letter to shareh
January 21, 2020 13:34
GeneMedicine Appoints MIT Professor Robert S. Langer, Sc.D to Its Scientific Advisory Board
GeneMedicine Co., Ltd., a leader in the field of oncolytic adenovirus platform for the treatment of intractable cancers, announced that the company has appointed Robert S. Langer, Sc.D., the David H.
January 21, 2020 10:41
Mundipharma Enters Partnership With Samsung Bioepis to Expand Biosimilars Into Hong Kong and Taiwan
Mundipharma today announced a partnership with Samsung Bioepis to commercialize Samsung Bioepis’ first-wave biosimilar candidates in Taiwan and Hong Kong. The partnership covers Samsung Bioepis’ bi
January 20, 2020 23:00
ResMed Introduces AirFit F30i, Its First Tube-up Full Face CPAP Mask
ResMed (NYSE: RMD) (ASX: RMD) today introduced AirFit F30i, its first tube-up full face CPAP mask, rounding out the most complete full face mask portfolio on the market. Full face CPAP users can no
January 20, 2020 10:37
Tej Kohli Foundation Moves One Step Closer to the Regeneration of Corneal Tissue to Cure Blindness
The Tej Kohli Foundation has moved one step closer to a non-surgical treatment for corneal blindness as it prepares to enter into a collaboration with researchers in Montreal, Canada and Moorfields Ey
January 17, 2020 08:44
OncoSec Board Rejects Alpha Holdings “Proposal” and Announces New Special Meeting Date
OncoSec Medical Incorporated (NASDAQ: ONCS) (the “Company” or “OncoSec”), a company developing late-stage intratumoral cancer immunotherapies, today announced that its Board of Directors (the “Board”)
January 16, 2020 09:50
AMR Life Science Industry 2020 Report: Successes and Setbacks in Fighting Superbugs
AMR Industry Alliance report released today provides a unique snapshot of the life science industry’s collective efforts in delivering on their commitments to tackle the rise of antimicrobial resistan
January 15, 2020 15:11
Takeda to Outline Progress on Business Transformation and Priorities at the 38th Annual J.P. Morgan Healthcare Conference
Takeda Pharmaceutical Company Limited (TOKYO:4502/NYSE:TAK) (“Takeda”) will provide an update on the progress of its business transformation and priorities today at the 38th Annual J.P. Morgan Healthc
January 15, 2020 13:49
Covetrus Enters Into Definitive Agreement to Divest scil animal care to Heska
Covetrus (NASDAQ: CVET), a global leader in animal-health technology and services, today announced that it has entered into a definitive agreement to sell its scil animal care business (“scil”) to Hes
January 15, 2020 09:06
GNT Pharma‘s Anti-dementia Drug ’crisdesalazine' Demonstrates Efficacy in Phase III Clinical Study with Companion Dogs with Dementia
GNT Pharma has successfully completed a Phase III clinical trial for crisdesalazine, a new drug for treating canine cognitive dysfunction syndrome or Alzheimer’s disease. In the clinical study cond
January 14, 2020 11:45
BLEED OUT Documentary Screening and Panel Discussion
Patient Safety Movement Foundation: WHAT: After a routine partial hip replacement operation leaves his mother in a coma with permanent brain damage, a son’s video diary becomes a citizen’s inves
25 per page50 per page75 per page100 per page